137 related articles for article (PubMed ID: 34696935)
1. Δcps1 vaccine protects dogs against experimentally induced coccidioidomycosis.
Shubitz LF; Robb EJ; Powell DA; Bowen RA; Bosco-Lauth A; Hartwig A; Porter SM; Trinh H; Moale H; Bielefeldt-Ohmann H; Hoskinson J; Orbach MJ; Frelinger JA; Galgiani JN
Vaccine; 2021 Nov; 39(47):6894-6901. PubMed ID: 34696935
[TBL] [Abstract][Full Text] [Related]
2. Viable spores of Coccidioides posadasii Δcps1 are required for vaccination and provide long lasting immunity.
Shubitz LF; Powell DA; Trinh HT; Lewis ML; Orbach MJ; Frelinger JA; Galgiani JN
Vaccine; 2018 May; 36(23):3375-3380. PubMed ID: 29724507
[TBL] [Abstract][Full Text] [Related]
3. Vaccine Protection of Mice With Primary Immunodeficiencies Against Disseminated Coccidioidomycosis.
Powell DA; Hsu AP; Butkiewicz CD; Trinh HT; Frelinger JA; Holland SM; Galgiani JN; Shubitz LF
Front Cell Infect Microbiol; 2021; 11():790488. PubMed ID: 35071044
[TBL] [Abstract][Full Text] [Related]
4. A Coccidioides posadasii CPS1 Deletion Mutant Is Avirulent and Protects Mice from Lethal Infection.
Narra HP; Shubitz LF; Mandel MA; Trinh HT; Griffin K; Buntzman AS; Frelinger JA; Galgiani JN; Orbach MJ
Infect Immun; 2016 Oct; 84(10):3007-16. PubMed ID: 27481239
[TBL] [Abstract][Full Text] [Related]
5. A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB/c mice against coccidioidomycosis.
Xue J; Chen X; Selby D; Hung CY; Yu JJ; Cole GT
Infect Immun; 2009 Aug; 77(8):3196-208. PubMed ID: 19487479
[TBL] [Abstract][Full Text] [Related]
6. Preclinical identification of vaccine induced protective correlates in human leukocyte antigen expressing transgenic mice infected with Coccidioides posadasii.
Hurtgen BJ; Castro-Lopez N; Jiménez-Alzate MDP; Cole GT; Hung CY
Vaccine; 2016 Oct; 34(44):5336-5343. PubMed ID: 27622300
[TBL] [Abstract][Full Text] [Related]
7. Whole glucan particles as a vaccine against systemic coccidioidomycosis.
Clemons KV; Antonysamy MA; Danielson ME; Michel KS; Martinez M; Chen V; Stevens DA
J Med Microbiol; 2015 Oct; 64(10):1237-1243. PubMed ID: 26297127
[TBL] [Abstract][Full Text] [Related]
8. Flow Cytometric Analysis of Protective T-Cell Response Against Pulmonary Coccidioides Infection.
Hung CY; Wozniak KL; Cole GT
Methods Mol Biol; 2016; 1403():551-66. PubMed ID: 27076153
[TBL] [Abstract][Full Text] [Related]
9. A vaccine against coccidioidomycosis is justified and attainable.
Cole GT; Xue JM; Okeke CN; Tarcha EJ; Basrur V; Schaller RA; Herr RA; Yu JJ; Hung CY
Med Mycol; 2004 Jun; 42(3):189-216. PubMed ID: 15283234
[TBL] [Abstract][Full Text] [Related]
10. EXPERIMENTAL VIABLE VACCINE AGAINST PULMONARY COCCIDIOIDOMYCOSIS IN MONKEYS.
CONVERSE JL; CASTLEBERRY MW; SNYDER EM
J Bacteriol; 1963 Nov; 86(5):1041-51. PubMed ID: 14080770
[TBL] [Abstract][Full Text] [Related]
11. The dog as a sentinel and animal model for coccidioidomycosis.
Ferguson AJ; Thompson GR; Bruyette D; Sykes JE
Med Mycol; 2024 Jan; 62(1):. PubMed ID: 38148116
[TBL] [Abstract][Full Text] [Related]
12. An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection.
Hung CY; Hurtgen BJ; Bellecourt M; Sanderson SD; Morgan EL; Cole GT
Vaccine; 2012 Jun; 30(31):4681-90. PubMed ID: 22575167
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis.
Herr RA; Hung CY; Cole GT
Infect Immun; 2007 Dec; 75(12):5777-87. PubMed ID: 17875631
[TBL] [Abstract][Full Text] [Related]
14. Vaccine immunity to coccidioidomycosis occurs by early activation of three signal pathways of T helper cell response (Th1, Th2, and Th17).
Hung CY; Gonzalez A; Wüthrich M; Klein BS; Cole GT
Infect Immun; 2011 Nov; 79(11):4511-22. PubMed ID: 21859851
[TBL] [Abstract][Full Text] [Related]
15. EXPERIMENTAL PRIMARY CUTANEOUS COCCIDIOIDOMYCOSIS IN THE MONKEY.
CONVERSE JL; PAKES SP; SNYDER EM; CASTLEBERRY MW
J Bacteriol; 1964 Jan; 87(1):81-5. PubMed ID: 14102877
[TBL] [Abstract][Full Text] [Related]
16. Rational Design of T Lymphocyte Epitope-Based Vaccines Against Coccidioides Infection.
Hurtgen BJ; Hung CY
Methods Mol Biol; 2017; 1625():45-64. PubMed ID: 28584982
[TBL] [Abstract][Full Text] [Related]
17. Saccharomyces cerevisiae as a vaccine against coccidioidomycosis.
Capilla J; Clemons KV; Liu M; Levine HB; Stevens DA
Vaccine; 2009 Jun; 27(27):3662-8. PubMed ID: 19464548
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of a potential vaccine for Coccidioides immitis.
Barnato AE; Sanders GD; Owens DK
Emerg Infect Dis; 2001; 7(5):797-806. PubMed ID: 11747691
[TBL] [Abstract][Full Text] [Related]
19. A recombinant aspartyl protease of Coccidioides posadasii induces protection against pulmonary coccidioidomycosis in mice.
Tarcha EJ; Basrur V; Hung CY; Gardner MJ; Cole GT
Infect Immun; 2006 Jan; 74(1):516-27. PubMed ID: 16369008
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the protective efficacy of the killed Coccidioides immitis spherule vaccine in humans. The Valley Fever Vaccine Study Group.
Pappagianis D
Am Rev Respir Dis; 1993 Sep; 148(3):656-60. PubMed ID: 8368636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
